XM does not provide services to residents of the United States of America.
K
K

KPN

News

KPN Calls EGM To Appoint Rob Shuter To Supervisory Board

BRIEF-KPN Calls EGM To Appoint Rob Shuter To Supervisory Board Aug 20 (Reuters) - Koninklijke KPN NV KPN.AS : KPN CALLS EGM TO APPOINT MR ROB SHUTER TO THE SUPERVISORY BOARD TO BE HELD AT KPN'S HEADQUARTERS IN ROTTERDAM ON TUESDAY 1 OCTOBER 2024 Source text for Eikon: ID:nGNE5JHvHb Further company coverage: KPN.AS (Gdansk Newsroom)
K

BofA sees headwinds for European telecoms in Q3, but better Q4

BUZZ-BofA sees headwinds for European telecoms in Q3, but better Q4 ** Bank of America expects headwinds to persist for European telecoms in the next three months, while it signals a better end to the year ** "Capex trends net positive but pricing becoming less stable, watch closely," BofA says ** Says domestic service revenue trends across Europea
D
F
K
P
S
T
T
U
V

Ascential Plc, Oxford Instruments, Reckitt Benckiser

EUROPE RESEARCH ROUNDUP-Ascential Plc, Oxford Instruments, Reckitt Benckiser July 25 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Ascential Plc, Oxford Instruments and Reckitt Benckiser, on Thursday. HIGHLIGHTS * Ascential Plc ASCL.L : HSBC raises target price to 568p from 370p * Oxford Instruments OXIG.L : HSBC raises target price to 2850p from 2500p * Reckitt Benckiser RKT.L : HSBC cuts target price to 4800p from 4900p * RS Gr
A
A
A
B
B
C
D
D
E
E
K
K
O
R
S
S
U
A
A
A
B
E

KPN On Track To Reach FY and Mid-Term Ambitions

BRIEF-KPN On Track To Reach FY and Mid-Term Ambitions July 24 (Reuters) - Koninklijke KPN NV KPN.AS : ON TRACK TO REACH FULL-YEAR 2024 OUTLOOK WE REMAIN ON TRACK TO DELIVER ON OUR MID-TERM AMBITIONS Source text for Eikon: ID:nGNE5V0RKT Further company coverage: KPN.AS (Gdansk Newsroom)
K

Barclays, Mips AB, Novo Nordisk

EUROPE RESEARCH ROUNDUP-Barclays, Mips AB, Novo Nordisk July 19 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Barclays, Mips AB and Novo Nordisk on Friday. HIGHLIGHTS * Barclays BARC.L : Jefferies raises target price to 341p from 335p * Mips AB MIPS.ST : Jefferies raises to buy from hold * Novo Nordisk NOVOB.CO : HSBC raises target price to DKK 1150 from DKK 1030 * Spectris SXS.L : HSBC raises target price to 3750p from 3425p * S
A
A
B
B
B
B
B
C
D
E
E
E
G
H
H
H
K
S
S
S
T
A
A

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.